Dik J Kwekkeboom
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate
Forrer F, de Herder W, van Lom K, de Jong M, Teunissen J, Bakker W, Konijnenberg M, Bernard B, Kooij P, Krenning E, Kwekkeboom D. Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate. Eur J Nucl Med Mol Imaging 2009; 36:1138-46.
Feb 27, 2009Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate
Feb 27, 2009Eur J Nucl Med Mol Imaging 2009; 36:1138-46
Forrer Flavio, de Herder Wouter W, van Lom Kirsten, de Jong Marion, Teunissen Jaap J M, Bakker Willem H, Konijnenberg Mark, Bernard Bert F, Kooij Peter P, Krenning Eric P, Kwekkeboom Dik J
Neuroendocrine tumors. Peptide receptor radionuclide therapy
Forrer F, Valkema R, Kwekkeboom D, de Jong M, Krenning E. Neuroendocrine tumors. Peptide receptor radionuclide therapy. Best Pract Res Clin Endocrinol Metab 2007; 21:111-29.
Mar 1, 2007Neuroendocrine tumors. Peptide receptor radionuclide therapy
Mar 1, 2007Best Pract Res Clin Endocrinol Metab 2007; 21:111-29
Forrer Flavio, Valkema Roelf, Kwekkeboom Dik J, de Jong Marion, Krenning Eric P